Ljubica V.
- Country
- Croatia
- Department
- Department for medical oncology
Research Overview
- Phase 3 Randomized Study of Petosemtamab and Pembrolizumab in First-Line Treatment of Recurrent/Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma
- Phase 3 Randomized, Double-Blind Study of Belrestotug and Dostarlimab Versus Pembrolizumab in PD-L1 High Non-Small Cell Lung Cancer
- Phase 3 Randomized Trial of Eftilagimod Alfa, Pembrolizumab, and Chemotherapy in Advanced/Metastatic Non-Small Cell Lung Cancer Patients
Data & Insights
Has run more than one trial at 60 of 265 partner sites.
Specializations
Thoracic Oncology and Targeted Cancer Therapy
Clinical research activity includes advanced and metastatic non-small cell lung cancer, KRAS G12C-mutated disease, and broader lung cancer settings, with interest in combination strategies involving immunotherapy and targeted agents.
- Non-small cell lung cancer
- KRAS G12C-mutated lung cancer
- Advanced and metastatic lung cancer
- Immune checkpoint-based combinations
Research involvement also extends to head and neck squamous cell carcinoma and other solid tumours requiring systemic treatment innovation.
Neurology and Multiple Sclerosis
Investigational work spans relapsing and progressive forms of multiple sclerosis, along with other neurological disorders such as refractory focal onset epilepsy and acute ischemic stroke.
- Relapsing-remitting multiple sclerosis
- Primary progressive multiple sclerosis
- Progressive multiple sclerosis
- Epilepsy and stroke prevention
There is also clinical interest in therapies aimed at delaying disability progression and addressing inflammatory disease activity within the central nervous system.
Inflammatory and Autoimmune Diseases
Research activity includes ulcerative colitis, Crohn’s disease, hidradenitis suppurativa, atopic dermatitis, and other immune-mediated disorders affecting the skin and gastrointestinal tract.
- Inflammatory bowel disease
- Hidradenitis suppurativa
- Atopic dermatitis
- Immune-mediated inflammatory conditions
Additional involvement includes bronchiectasis and IgA nephropathy, reflecting interest in chronic inflammatory and immune-driven organ disease.
Hematology and Onco-Hematology
Clinical trial participation covers diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and myelofibrosis, with attention to relapsed or refractory blood cancers.
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Multiple myeloma
- Myelofibrosis
Research also includes immune thrombocytopenia, supporting a broader focus on hematologic malignancies and immune-mediated blood disorders.
Cardiometabolic, Renal, and Endocrine Disorders
Areas of interest include atrial fibrillation, acute myocardial infarction, atherosclerotic cardiovascular disease, heart failure, and hypertrophic cardiomyopathy, alongside renal cell carcinoma and IgA nephropathy.
- Cardiovascular disease
- Heart failure and cardiomyopathy
- Renal cell carcinoma
- Metabolic disease and obesity
Additional trial involvement includes prostate cancer, breast cancer, and thyroid cancer, broadening the therapeutic portfolio across solid tumours and chronic disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.